Evidence map›Paper›PMID 10811864›Full record

ArticleThe Journal of experimental medicine2000

Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2.

M Haraguchi, S Torii, S i Matsuzawa, Z Xie, S Kitada, S Krajewski, H Yoshida, T W Mak, J C Reed

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 159 citations in OpenAlex.

  1. Review
  2. A metabolic cell death program downstream of SARM1 couples NADProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Targeting apoptotic caspases in cancer.Biochimica et biophysica acta. Molecular cell research · 2020
    Review
  9. Review
  10. Article
  11. MOMP, cell suicide as a BCL-2 family business.Cell death and differentiation · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

M HaraguchiBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037, USA.
S Torii
S i Matsuzawa
Z Xie
S Kitada
S Krajewski
H Yoshida
T W Mak
J C Reed
Sanford Burnham Prebys Medical Discovery Institute · USOntario Institute for Cancer Research · CA

Funding

Mitochondria and Apoptosis (revised GM60554)R01GM060554 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REED, JOHN C · 2000 to 2009
$3.5M
NIGMS NIH HHS GM60554NIGMS NIH HHS R01 GM060554
6 · The paper itself

Abstract

Reportedly, antiapoptotic Bcl-2 family proteins suppress apoptosis by binding to and inhibiting members of the CED-4 family of caspase activators. To explore this question, we used embryonic stem (ES) cells in which one (-/+) or both (-/-) copies of the gene encoding apoptotic protease activating factor 1 (Apaf-1), a CED-4 homologue, were disrupted by homologous recombination. Stable clones of heterozygous (-/+) and homozygous (-/-) Apaf-1 knockout ES cells that overexpressed Bcl-2 were generated. Withdrawal of serum growth factors or stimulation of heterozygous ES cells with staurosporine (STS), ultraviolet (UV)B irradiation, etoposide (VP16), or cisplatin induced apoptosis followed by cell death (determined by failure to exclude propidium iodide dye). These cell death stimuli also induced activation of several types of caspases and loss of mitochondrial membrane potential (DeltaPsi) in heterozygous (+/-) Apaf-1 knockout ES cells. In addition, overexpression of Bcl-2 protected against these events in Apaf-1-expressing ES cells. In contrast, STS, UVB, and VP16 induced little or no caspase activation and apoptosis in homozygous (-/-) Apaf-1 knockout ES cells. Nevertheless, Apaf-1-deficient ES cells subjected to these cell death stimuli or deprived of growth factors did eventually die through a nonapoptotic mechanism associated with loss of DeltaPsi. Moreover, Bcl-2 overprotection preserved DeltaPsi, reduced the percentage of Apaf-1(-/)- ES cells undergoing cell death, and increased clonigenic survival. The extent of Bcl-2-mediated cytoprotection was not significantly different for heterozygous (-/+) versus homozygous (-/-) Apaf-1 knockout cells. Furthermore, although Bcl-2 could be readily coimmunoprecipitated with Bax, associations with Apaf-1 were undetectable under conditions where Apaf-1 interactions with procaspase-9 were observed. We conclude that Bcl-2 has cytoprotective functions independent of Apaf-1, preserving mitochondrial function through a caspase-independent mechanism.

Indexed as

Amino Acid SequenceAnimalsAntineoplastic AgentsApoptosisApoptotic Protease-Activating Factor 1bcl-2-Associated X ProteinCaspasesCell DeathClone CellsEnzyme ActivationGene ExpressionGenes, bcl-2MiceMice, KnockoutMicroscopy, ElectronOligopeptidesAntineoplastic AgentsApaf1 protein, mouseApoptotic Protease-Activating Factor 1Bax protein, mousebcl-2-Associated X ProteinCaspasesOligopeptidesProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID10811864
PMCPMC2193150
OpenAlexW2135109846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.